Cystatin C is now considered a superior marker when compared with sCr in both animal models and clinical settings of chronic kidney disease.26,27 However, it is unclear whether the value of cystatin C is generarizable to all forms of AKI or not. This evidence concerns the gene CST3 and acute kidney injury.